Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Arlene Chapman

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Chapman, Arlene

Item TypeName
Concept Receptors, Vasopressin
Academic Article Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?
Academic Article Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
Academic Article Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
Academic Article Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Academic Article Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.
Academic Article Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial.
Academic Article Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
Academic Article Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial.
Academic Article Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.
Academic Article Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
Academic Article Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.
Academic Article Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Academic Article A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
Academic Article Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.

Search Criteria
  • Receptors Vasopressin